Insider · CIK 0001794018
Joseph Hulihan
officer
Files at MRNS (MARINUS PHARMACEUTICALS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -17,155 | $0.55 | $9,435 | 55,570 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -55,570 | $0.55 | $31k | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -49,125 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -98,250 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -115,418 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -77,175 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -115,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,250 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -100,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.